William Blair Comments on Addus HomeCare Co.’s Q2 2022 Earnings (NASDAQ:ADUS)

Addus HomeCare Co. (NASDAQ:ADUSGet Rating) – Stock analysts at William Blair dropped their Q2 2022 earnings per share estimates for Addus HomeCare in a research note issued on Tuesday, May 3rd. William Blair analyst M. Larew now anticipates that the company will post earnings per share of $0.82 for the quarter, down from their previous estimate of $1.01. William Blair also issued estimates for Addus HomeCare’s Q3 2022 earnings at $0.84 EPS, Q4 2022 earnings at $0.93 EPS, FY2022 earnings at $3.25 EPS, Q1 2023 earnings at $0.91 EPS, Q2 2023 earnings at $0.90 EPS, Q3 2023 earnings at $0.98 EPS, Q4 2023 earnings at $0.93 EPS and FY2023 earnings at $3.71 EPS.

Other equities analysts have also recently issued research reports about the stock. StockNews.com started coverage on shares of Addus HomeCare in a research note on Thursday, March 31st. They set a “buy” rating for the company. Zacks Investment Research cut shares of Addus HomeCare from a “hold” rating to a “sell” rating in a research note on Monday. Royal Bank of Canada reduced their price objective on shares of Addus HomeCare from $125.00 to $111.00 in a research note on Wednesday. Finally, Bank of America started coverage on shares of Addus HomeCare in a research note on Wednesday, April 13th. They set a “buy” rating and a $110.00 price objective for the company. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $105.50.

ADUS opened at $80.49 on Friday. The company has a market capitalization of $1.29 billion, a price-to-earnings ratio of 28.95, a PEG ratio of 2.16 and a beta of 0.87. The company has a quick ratio of 2.76, a current ratio of 2.65 and a debt-to-equity ratio of 0.44. The firm has a 50-day moving average price of $84.53 and a 200-day moving average price of $86.23. Addus HomeCare has a twelve month low of $68.57 and a twelve month high of $108.11.

Addus HomeCare (NASDAQ:ADUSGet Rating) last posted its earnings results on Monday, May 2nd. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.10. Addus HomeCare had a net margin of 5.05% and a return on equity of 8.83%. During the same period in the prior year, the business earned $0.62 earnings per share.

In other news, CEO R Dirk Allison sold 1,432 shares of the business’s stock in a transaction that occurred on Wednesday, March 2nd. The shares were sold at an average price of $84.22, for a total value of $120,603.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Brian Poff sold 448 shares of the business’s stock in a transaction that occurred on Wednesday, March 2nd. The stock was sold at an average price of $84.22, for a total transaction of $37,730.56. The disclosure for this sale can be found here. In the last three months, insiders sold 5,256 shares of company stock valued at $403,669. Corporate insiders own 4.00% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in ADUS. Okabena Investment Services Inc. bought a new stake in Addus HomeCare during the 4th quarter valued at $31,000. Public Employees Retirement System of Ohio raised its holdings in Addus HomeCare by 41.8% during the 4th quarter. Public Employees Retirement System of Ohio now owns 448 shares of the company’s stock valued at $42,000 after buying an additional 132 shares during the last quarter. Marshall Wace North America L.P. bought a new stake in Addus HomeCare during the 1st quarter valued at $34,000. Financial Management Professionals Inc. bought a new stake in Addus HomeCare during the 1st quarter valued at $72,000. Finally, US Bancorp DE raised its holdings in Addus HomeCare by 28.1% during the 3rd quarter. US Bancorp DE now owns 871 shares of the company’s stock valued at $69,000 after buying an additional 191 shares during the last quarter. Hedge funds and other institutional investors own 96.04% of the company’s stock.

Addus HomeCare Company Profile (Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Earnings History and Estimates for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.